New drug shows promise for Tough-to-Treat bladder cancer before surgery

This study tested a drug called sacituzumab govitecan given before bladder removal surgery in 44 people with muscle-invasive bladder cancer who could not take or refused standard cisplatin chemotherapy. The goal was to see if the drug could completely eliminate the tumor by the time of surgery. The study also looked at how well the drug shrank tumors on scans and how safe it was.